Press releasePRNewswire
Nexpoint Real Estate Finance
NREF · NYSE
$15.50+$0.35 (+2.31%)TodayMarket closed ·
Prev close $15.15
About NREF
- Employees
- 1
- Headquarters
- Dallas, Texas
- Listed
- Feb 7, 2020
- Sector
- Financials
- Industry
- Mortgage Real Estate Investment Trusts (REITs)
- Website
- nexpointfinance.com
NREF key statistics
- Market cap
- 292.14M
- Price-earnings ratio
- 6.67
- Dividend yield
- 24.99%
- Average volume
- 58.58K
- Volume
- 47.33K
- Open price
- $15.19
- High today
- $15.69
- Low today
- $15.19
- 52 Week high
- $18.43
- 52 Week low
- $12.36
Nexpoint Real Estate Finance (NREF) at a glance
Nexpoint Real Estate Finance (NREF) last traded at $15.50, with a market cap of 292.14M, a price-to-earnings ratio of 6.67 and a dividend yield of 24.99%.
Today the stock has traded between $15.19 and $15.69. The current price is 2.0% above the day's low and 1.2% below its high.
Volume so far is 47.33K shares, in line with the average of 58.58K shares a day.
Over the past year Nexpoint Real Estate Finance has ranged from $12.36 to $18.43, and now sits 52% of the way up that range.
Nexpoint Real Estate Finance met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $0.46 per share against an estimate of $0.459.
The average analyst price target is $17.08, 10.2% above the current price, from 2 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
0%of 2 analyst ratings say Buy
- Buy0.0%
- Hold100.0%
- Sell0.0%
Price target · 4 analystsAvg $17.08
- Low
- $16.16
- Now
- $15.50
- High
- $18.38
NREF earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 16.0% on average.
- Q3 FY24: reported $0.75 per share against an estimate of $0.4896
- Q4 FY24: reported $0.83 per share against an estimate of $0.7726
- Q1 FY25: reported $0.41 per share against an estimate of $0.4998
- Q2 FY25: reported $0.43 per share against an estimate of $0.4726
- Q3 FY25: reported $0.51 per share against an estimate of $0.4794
- Q4 FY25: reported $0.47 per share against an estimate of $0.5125
- Q1 FY26: reported $0.43 per share against an estimate of $0.3808
- Q2 FY26: reported $0.46 per share against an estimate of $0.459
NREF news
- Press releasePRNewswire
NexPoint Real Estate Finance, Inc. Announces Series A Preferred Stock Dividend
- Press releasePRNewswire
NREF Announces Second Quarter 2026 Results, Provides Third Quarter 2026 Guidance
- Press releasePRNewswire
NexPoint Real Estate Finance, Inc. Announces Quarterly Dividend
- Press releasePRNewswire
NexPoint Real Estate Finance, Inc. Announces Second Quarter 2026 Earnings Conference Call
- Press releasePRNewswire
NexPoint Real Estate Finance, Inc. Announces Series A Preferred Stock Dividend
- Press releasePRNewswire
NREF Announces First Quarter 2026 Results, Provides Second Quarter 2026 Guidance
- Press releasePRNewswire
NexPoint Real Estate Finance, Inc. Announces Quarterly Dividend
Similar companies
Companies in the same industry as Nexpoint Real Estate Finance
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.